Due to essential maintenance on Enlighten, links to individual publications may be temporarily unavailable
Number of items: 5.
2013
Roxburgh, P., Hock, A.K., Dickens, M.P., Mezna, M., Fischer, P.M., and Vousden, K.H.
(2013)
Small molecules that bind the Mdm2 RING stabilize and activate p53.
Carcinogenesis
.
ISSN 0143-3334
(doi:10.1093/carcin/bgs092)
(In Press)
2011
Lolkema, M. P. et al.
(2011)
A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.
Clinical Cancer Research, 17
(3).
pp. 581-588.
ISSN 1078-0432
(doi:10.1158/1078-0432.CCR-10-2159)
Roxburgh, P., Reed, N., and Glasspool, R.
(2011)
Experience of weekly carboplatin and paclitaxel in treatment resistant ovarian cancer.
European Journal of Clinical and Medical Oncology, 3
(4).
ISSN 1759-8958
2010
Gourley, C. et al.
(2010)
Increased incidence of visceral metastases in Scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype.
Journal of Clinical Oncology, 28
(15).
pp. 2505-2511.
ISSN 0732-183X
(doi:10.1200/JCO.2009.25.1082)
2008
Roxburgh, P, and Evans, TR
(2008)
Systemic therapy of hepatocellular carcinoma: Are we making progress?
Advances in Therapy, 25
(11).
pp. 1089-1104.
ISSN 0741-238X
(doi:10.1007/s12325-008-0113-z )
This list was generated on Thu Mar 14 19:44:39 2013 GMT.
